Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Glaritus 100IU/ml Injection 3ml

Prescription Icon
Prescription Required

Marketer

Wockhardt Ltd

Salt Composition

Insulin Glargine (100IU)

Overview Glaritus 100IU/ml Injection 3ml

InsuLinR 100IU/ml (3ml) is a prolonged-release insulin formulation indicated for managing type 1 and type 2 diabetes mellitus in pediatric and adult patients. Providing consistent, 24-hour glycemic control, it helps mitigate diabetes-related complications. InsuLinR may be administered alone or in conjunction with rapid-acting insulin or other antidiabetic agents. Proper subcutaneous injection technique will be demonstrated by your healthcare provider. Adherence to the prescribed dosage is crucial for optimal therapeutic outcomes; discontinuation can lead to severe hyperglycemia. This medication forms part of a comprehensive diabetes management plan, encompassing dietary modifications, physical activity, and weight management as directed by your physician. Hypoglycemia is the most frequently reported adverse event; accurate dosing, regular meals, and blood glucose monitoring are essential for its prevention. Excessive alcohol consumption increases hypoglycemia risk. Additional potential side effects include peripheral edema, lipoatrophy/lipohypertrophy, hypersensitivity reactions, injection site reactions, pruritus, skin rash, and weight increase. Avoid use in hypoglycemic states. Prior to initiating therapy, disclose any existing renal, hepatic, or cardiac conditions. Consult your physician before using InsuLinR during pregnancy or lactation.

Primary Ingredients of Glaritus 100IU/ml Injection 3ml

No information provided. Please provide the text you wish me to rephrase.

Uses of Glaritus 100IU/ml Injection 3ml

Elevated blood glucose

Major Benefits of Glaritus 100IU/ml Injection 3ml:

This medication will be administered by your doctor or nurse. Home administration instruction will be provided to you or your caregiver, as appropriate.

Common Side effects of Glaritus 100IU/ml Injection 3ml:

  • Hypoglycemia (low blood glucose level)
  • Peripheral edema
  • Lipodystrophy (skin thickening or pits at the injection site)
  • Allergic reaction
  • Injection site reactions (pain, swelling, redness)
  • Itching
  • Rash
  • Weight gain

How to use Glaritus 100IU/ml Injection 3ml:

This medication will be administered by your physician or registered nurse. Home administration may be taught to you or your caregiver.

How Glaritus 100IU/ml Injection 3ml works:

Glargine 100 IU/mL injection (3 mL) offers extended insulin action for stable, 24-hour glycemic management. Mimicking the body's natural insulin, it promotes glucose uptake by muscle and fat tissues while simultaneously inhibiting hepatic glucose output.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glaritus 100IU/ml Injection 3ml with alcohol is inadvisable.

PregnancyPregnancySAFE IF PRESCRIBED

The injectable medication Glaritus, 100 IU/ml concentration in a 3ml vial, is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; clinical data from human studies, however, remain scarce.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Breastfeeding mothers may likely use Glaritus 100 IU/ml Injection (3ml) without significant risk to their infants. Available human data indicates minimal infant exposure concern.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Individuals with impaired kidney function should use Glaritus 100IU/ml Injection 3ml cautiously. A modified dosage of Glaritus 100IU/ml Injection 3ml might be necessary. Physician consultation is advised. Routine blood glucose monitoring is recommended to guide dosage modifications.

LiverLiverCAUTION

Patients with liver impairment should use Glaritus 100 IU/mL injection (3 mL) cautiously, as dosage modification may be necessary. Physician consultation is advised. Routine glucose monitoring is recommended to guide dosage changes.

What if you forget to take Glaritus 100IU/ml Injection 3ml :

Should you forget a dose of Glaritus 100IU/ml Injection (3ml), administer it promptly. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glaritus 100IU/ml Injection 3ml

LabelValue
Chemical Category Modified insulin
Developing Habits No.
Treatment Category Diabetes Treatment
Behavior Class Long-acting insulin analogs

FAQs on Glaritus 100IU/ml Injection 3ml

Glaritus 100IU/ml Injection (3ml), a synthetic insulin closely resembling human insulin, provides a prolonged, consistent reduction in blood glucose levels for up to 24 hours. This allows for once-daily administration in adults with type 1 or type 2 diabetes mellitus, and in children with type 1 diabetes.
Glaritus 100IU/ml Injection (3ml) is administered subcutaneously. Your doctor will demonstrate the proper injection technique and suitable injection sites (abdomen, thighs, arms, hips, or buttocks). Rotate injection sites within the chosen area for each dose; for example, vary stomach injection sites by approximately 1cm. Alternate injection sides (e.g., right then left) daily. Rotating injection areas helps prevent complications like lipodystrophy (fat tissue thickening), irritation, and pain. After one to two weeks, change injection areas as directed by your doctor. Contact your doctor if you experience any problems.
Glaritus 100 IU/ml Injection (3ml), a long-acting medication, is typically administered once daily. While the time of day is flexible, consistency is recommended.
Taking more than the recommended dose of Glaritus 100IU/ml Injection 3ml can cause dangerously low blood sugar (hypoglycemia). This can range from mild symptoms (anxiety, sweating, weakness, tremors, rapid heartbeat) to severe cases causing seizures or unconsciousness. Monitor your blood sugar closely for 24 hours. Treat mild hypoglycemia with sugary foods like candy or fruit juice. Severe hypoglycemia requires immediate emergency medical attention. Consult your doctor for further guidance.
Keep this medication, in its original container, out of children's reach. Unopened vials and pens should be refrigerated, but not frozen. Refrigerate unopened Glaritus 100IU/ml Injection 3ml vials until the expiration date on the label. Never use Glaritus 100IU/ml Injection 3ml that has been frozen or thawed. If refrigeration isn't possible, store vials at room temperature, protected from direct sunlight and excessive heat. The solution should be clear, colorless, and particle-free.
Discuss insulin dose adjustments with your doctor. Closely monitor blood sugar if unwell. Inform your doctor of all medications, as many can interact with insulin and require dose changes. Your insulin dose may also need adjusting based on changes in diet (e.g., missed meals, altered food intake) and activity levels, alcohol use, or stress. Pregnant or breastfeeding women should consult their doctor before using Glaritus 100IU/ml Injection 3ml, as dose modifications may be necessary.
Glaritus 100IU/ml Injection 3ml rarely causes serious side effects. However, severe allergic reactions, including rash, hives, itching, breathing difficulties (wheezing), rapid heartbeat, and low blood pressure, are possible; seek immediate medical attention if these occur. Other potential side effects include severe hypoglycemia (low blood sugar), manifesting as dizziness, sweating, anxiety, confusion, headache, blurred vision, slurred speech, tremors, rapid heartbeat, seizures, and unconsciousness. Concomitant use of TZDs (thiazolidinediones) may increase the risk of heart failure, even in those without pre-existing heart conditions. Sudden weight gain and ankle or foot swelling (edema) may also occur. Report any of these side effects to your doctor immediately.
Glaritus 100IU/ml Injecti...
1,706
MRP 1,880
9% off